Yes, Mr. Chair.
There are two quick issues. First, I would say, is the availability of supplies, which we'll crack the back of in the fullness of time.
Second, I would say there is a divide sometimes between public health professionals and infectious disease specialists and epidemiologists about the value of testing large populations. I would err on the side of more data allowing us to answer questions better in the long term with a dataset that will allow future investigators to understand this pandemic better than most. I would also love to see Canada as the place with the most robust dataset.